FDA Approves Autoinjector Pen for Humira Biosimilar, Cyltezo

The drug will be commercially available on July 1, 2023.
Medscape Medical News

source https://www.medscape.com/viewarticle/992277?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?